Results 121 to 130 of about 6,415,892 (312)
Research Progress of Music Therapy on Gait Intervention in Patients with Parkinson’s Disease
Music therapy is an effective way to treat the gait disorders caused by Parkinson’s disease. Rhythm music stimulation, therapeutic singing, and therapeutic instrument performance are often used in clinical practice. The mechanisms of music therapy on the
Qiuxia Zhang +8 more
core +1 more source
Stage‐Dependent β‐Synuclein Links MRI and Cognitive Decline in Alzheimer's Disease
ABSTRACT Objective Synaptic degeneration drives cognitive decline in Alzheimer's disease (AD), but synaptic biomarkers are scarce. Brain‐enriched β‐synuclein emerged as a synaptic damage marker. We investigated its diagnostic, prognostic, and structural correlates across the AD continuum.
Ulaş Ay +15 more
wiley +1 more source
Automated online cognitive assessments are set to revolutionise clinical research and healthcare. However, their applicability for Parkinson’s Disease (PD) and REM Sleep Behavioural Disorder (RBD), a strong PD precursor, is underexplored.
Maria Bălăeţ +13 more
doaj +1 more source
Additional file 3. Table with secondary outcomes of UPDRS-4.
Hannink, K. +8 more
openaire +1 more source
Characteristics of studies included in the Meta-analysis. Including information of first author, year of publication, country, study design, number of patients and controls, duration of follow-up. (PDF 74Â kb)
Huang, Pei +3 more
openaire +1 more source
Data‐Driven SuStaIn Model of Disability Progression in Amyotrophic Lateral Sclerosis
ABSTRACT Objective To determine whether ordinal Subtype and Stage Inference (SuStaIn) applied to routine ALSFRS‐R item scores can identify reproducible disability progression patterns in amyotrophic lateral sclerosis (ALS) and provide clinically meaningful staging.
Giammarco Milella +5 more
wiley +1 more source
A case of neuroleptic malignant syndrome on withdrawal of benzhexol [PDF]
The neuroleptic malignant syndrome is a rare and potentially lethal reaction which is usually associated with the use of medications with antidopaminergic properties.
Ferry, Peter +2 more
core
Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2024 Update [PDF]
Background: For the past five years, our annual reports have been tracking the clinical development of new drug-based therapies for the neurodegenerative condition of Parkinson’s disease (PD). These reviews have followed the progress both of “symptomatic
Buff, S +10 more
core +1 more source
ABSTRACT Objective Blood biomarkers are increasingly critical for non‐invasive Alzheimer's Disease (AD) diagnostics and research but typically require on‐site processing. Remote point‐of‐care collection methods could enhance biomarker testing in clinical and research settings.
Sara Ho +9 more
wiley +1 more source
Table S1. Overview of the selected RCTs and Pilot Studies (PDF 276 kb)
Garcia-Agundez, Augusto +7 more
openaire +1 more source

